JPMorgan Chase & Co. (JPM)

107.51
0.03 0.03
NYSE : Finance
Prev Close 107.54
Open 107.10
Day Low/High 106.53 / 108.21
52 Wk Low/High 86.61 / 119.33
Volume 11.00M
Avg Volume 14.24M
Exchange NYSE
Shares Outstanding 3.40B
Market Cap 366.18B
EPS 6.30
P/E Ratio 15.30
Div & Yield 2.24 (2.02%)
Why Warren Buffett's Investment Style Is Fumbling the Ball

Why Warren Buffett's Investment Style Is Fumbling the Ball

Maybe you should not emulate the Oracle after all.

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

The Federal Reserve's "stress tests" of big banks required them to maintain sufficient capital even after a nightmare economic scenario where stock prices fell by 65% and unemployment surged to 10%.

JPMorgan Chase Announces 2018 Dodd-Frank Act Stress Test Results

JPMorgan Chase Announces 2018 Dodd-Frank Act Stress Test Results

JPMorgan Chase & Co. (NYSE: JPM) ("JPMorgan Chase" or the "Firm") announced today that it has released the results of its company-run 2018 Dodd-Frank Act Stress Test for JPMorgan Chase & Co.

See How JPMorgan Chase Ranks Among Analysts' Top Dow 30 Picks

See How JPMorgan Chase Ranks Among Analysts' Top Dow 30 Picks

A study of analyst recommendations at the major brokerages shows that JPMorgan Chase & Co is the #17 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Within the broader S&P 500, when components were ranked in terms of analyst favorites, JPM claims the #275 spot.

Jim Cramer: I Think Deregulation Will Produce Very Good Earnings for Banks

Jim Cramer: I Think Deregulation Will Produce Very Good Earnings for Banks

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer this regulation will help the bottom lines of banks, but acknowledges the lackluster performance recently of the financials sector.

A Technical View of Our Most Recent Addition

JPMorgan’s chart presents a unique opportunity.

Fed Chair Jerome Powell Is In a Tough Spot: Market Recon

Fed Chair Jerome Powell Is In a Tough Spot: Market Recon

The Fed Chair's problems are very different from anything his predecessors faced.

Under Armour, Cognex, Novocure: 'Mad Money' Lightning Round

Under Armour, Cognex, Novocure: 'Mad Money' Lightning Round

Jim Cramer weighs in on Under Armour, Cognex, Novocure, FireEye, Weight Watchers, Bristol-Meyers Squibb and Chegg.

The Name of the Game Is Growth: Cramer's 'Mad Money' Recap (Wednesday 6/20/18)

The Name of the Game Is Growth: Cramer's 'Mad Money' Recap (Wednesday 6/20/18)

Jim Cramer explains why the fulcrum for the financial markets is growth -- not tariffs, or the Fed, or interest rates.

The Fed's 2018 CCAR Begins Tomorrow

The annual Comprehensive Capital Analysis Review is commonly referred to as its 'stress test.'

3 Things to Know About the New Head of Amazon's Joint Stab at U.S. Healthcare

3 Things to Know About the New Head of Amazon's Joint Stab at U.S. Healthcare

Dr. Atul Gawande will become CEO of the new, unnamed company, effective July 9.

Four Trades: Two Trims, One Exit, One Initiation

We will prudently trim Amazon and McCormick; exit MGM Resorts; and add JPMorgan Chase to the portfolio.

Banks Prepare to Up Shareholder Payouts By $30 Billion

Banks Prepare to Up Shareholder Payouts By $30 Billion

Despite market sell offs, it's a good time to be shareholder in JPMorgan Chase & Co., Bank of America Corp. or Citigroup Inc.

Goldman Will Pay Big Money for Cash -- Yes, Even Your Measly Savings

Goldman Will Pay Big Money for Cash -- Yes, Even Your Measly Savings

Goldman Sachs, the elite Wall Street powerhouse, is under pressure to diversify its business mix beyond the traditional emphasis on investment banking and stock-and-bond trading. So it's pushing hard to build up an online retail bank for ordinary savers -- and offering some of the highest rates in the U.S. to lure them in.

Sarepta Shares Skyrocket on Early Results for DMD Gene Therapy

Sarepta Shares Skyrocket on Early Results for DMD Gene Therapy

The Duchenne Muscular Dystrophy specialist announces early results that show a gene-based treatment for the debilitating disease may be just two years away.

Amazon, Nvidia, Micron and 10 Other Stocks to Own in June

Amazon, Nvidia, Micron and 10 Other Stocks to Own in June

These stocks are ones you should put on your watch list for June. Buy, buy, buy.

Chase Is Rolling Out The BizMobile, A Business Advice Center On Wheels. (Photo: Business Wire)

Chase Is Rolling Out The BizMobile, A Business Advice Center On Wheels. (Photo: Business Wire)

In this age of food trucks and pop-up shops, Chase is rolling out the BizMobile, a business advice center on wheels.

J.P. Morgan Asset Management Launches US REIT ETF Based On MSCI US REIT Index

J.P. Morgan Asset Management Launches US REIT ETF Based On MSCI US REIT Index

--JPMAM launches BBRE, based on MSCI US REIT Index--

Weekly Roundup

Rate hikes and trade wars weighed on stocks this week.

JPMorgan Chase Declares Preferred Stock Dividend

JPMorgan Chase Declares Preferred Stock Dividend

JPMorgan Chase & Co. (NYSE: JPM) ("JPMorgan Chase" or the "Firm") declared dividends on the outstanding shares of the Firm's Series I, R and S preferred stock.

Jim Cramer: The Real Reason Banks Aren't Rallying

Jim Cramer: The Real Reason Banks Aren't Rallying

There's more holding back bank shares than a flat yield curve.

JPM's Head of North America M&A Wants to Super-Charge M&A and Hire More Women

JPM's Head of North America M&A Wants to Super-Charge M&A and Hire More Women

Listen to Anu Aiyengar talk trends in M&A and how she's activley recruiting more women to the firm.

REPLAY: Jim Cramer on JPMorgan, Amazon, Walmart, Netflix and Salesforce

REPLAY: Jim Cramer on JPMorgan, Amazon, Walmart, Netflix and Salesforce

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Thursday's trending stocks from the floor of the New York Stock Exchange.

Bank Stocks Poised to Gain, Aided by a Hawkish Fed

Bank Stocks Poised to Gain, Aided by a Hawkish Fed

Goldman Sachs (GS), Citigroup (C) and JPMorgan (JPM) all dipped 0.11 percent, 1.4 percent and 1.6 percent respectively in afternoon trading on Thursday following the Federal Reserve's announcement Wednesday that it is raising interest rates a quarter percent, in addition to adding two more hikes this year. In the long run however, a more hawkish Fed could bring big gains to bank stocks, experts say.

A Mixed Day on Thursday

We've looked around our portfolio at tech, steel, retail and the banks.

Jim's Daily Rundown

Jim discusses Comcast's offer for Fox, Kohl's, Amazon, 3M, JPMorgan, Goldman Sachs, Citigroup and more!

How a Wall Street Intern Could Become an Investment Bank CEO

How a Wall Street Intern Could Become an Investment Bank CEO

Hey sport, interested in going from summer intern at an investment bank to running an investment bank? Take some quick advice from the success story that is Stifel Financial CEO Ron Kruszewski.

Jim Cramer: I Want the Financials Stocks To Go Higher

Jim Cramer: I Want the Financials Stocks To Go Higher

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer wants the bank stocks to move higher.

TheStreet Quant Rating: A- (Buy)